Concurrent stressors Telogen effluvium responds to cumulative physiological stress
Saxenda Saxenda (liraglutide) is another GLP-1 receptor agonist which is FDA-approved for weight management administered subcutaneously (under the skin) daily. It works like other GLP-1 receptor agonists to help patients lose weight in addition to healthy lifestyle choices
Worth watching whether Lilly challenges the ANDA or how patent litigation timing affects that 10-month review estimate in practice
N Engl J Med 359(23):24562467 Cleland JGF, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J et al (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study
All eight reported studies have demonstrated the noninferiority of GLP-1RAs compared to placebo regarding MACE
Fiber without adequate water makes constipation worse, not better